Award
National Institute of Diabetes and Digestive and Kidney Diseases 11006975
Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
Recipient
Not specified
Award Amount
$306,872.00
Ceiling
$306,872.00
Awarded
May 22, 2025
Identifier
11006975
NIH NIDDK awarded approximately $306,872 for a project developing NeuWave, a wearable device using electromagnetic fields to treat type 2 diabetes, including preclinical studies and preparation for clinical testing.
Description
The project aims to develop a digital therapeutic platform called NeuWave, a wearable device for managing type 2 diabetes using electromagnetic fields during sleep. The project includes animal studies in lean and obese-diabetic rats to assess feasibility, safety, and biomarkers. The goal is to support FDA IDE submission and early clinical testing. The project emphasizes non-invasive, targeted electromagnetic therapy to improve insulin sensitivity and glucose metabolism.